Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
62M
Number of holders
121
Total 13F shares, excl. options
54.9M
Shares change
-5.09M
Total reported value, excl. options
$181M
Value change
-$21.6M
Put/Call ratio
1.12
Number of buys
47
Number of sells
-79
Price
$3.29

Significant Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) as of Q3 2024

165 filings reported holding MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share as of Q3 2024.
MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 54.9M shares of 62M outstanding shares and own 88.6% of the company stock.
Largest 10 shareholders include Bellevue Group AG (9.93M shares), ARMISTICE CAPITAL, LLC (6.26M shares), BlackRock, Inc. (5.41M shares), VANGUARD GROUP INC (4.36M shares), MILLENNIUM MANAGEMENT LLC (3.54M shares), Frazier Life Sciences Management, L.P. (3.01M shares), WASATCH ADVISORS LP (2.54M shares), STATE STREET CORP (1.43M shares), GEODE CAPITAL MANAGEMENT, LLC (1.41M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.25M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.